Acciones GSRX Industries Inc. Other OTC
Acciones
GSRX
US36255V1070
Farmacéuticos
Ventas 2018 | 2,68 2,47 | Ventas 2019 | 11 10,13 | Capitalización | 1,34 M 1,24 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -16 M -14,72 M | Resultado Neto 2019 | -36 M -33,13 M | VE / Ventas 2018 | 26.486.381 x |
Posición de caja neta 2018 | 1,31 M 1,21 M | Deuda neta 2019 | 2,27 M 2,09 M | VE / Ventas 2019 | 328.290 x |
P/E ratio 2018 |
-4,29
x | P/E ratio 2019 |
-0,03
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 13,26 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/03/20 |
Director of Finance/CFO | 63 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/03/20 |
Jeff Rogers
BRD | Director/Board Member | 61 | 10/03/20 |
Shaun Dale
BRD | Director/Board Member | 47 | 23/04/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+42,60 % | 748 mil M | |
+33,16 % | 598 mil M | |
-5,74 % | 356 mil M | |
+17,79 % | 325 mil M | |
+3,37 % | 283 mil M | |
+17,09 % | 245 mil M | |
+9,11 % | 211 mil M | |
-3,93 % | 209 mil M | |
+6,74 % | 165 mil M |